Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 study evaluating the safety, tolerability, and pharmacokinetics of cefiderocol in hospitalized neonates and infa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gram-negative Bacterial Infections

Drugs mentioned

• Cefiderocol (cefiderocol)

Snippet

Sponsor: Shionogi | Conditions: Gram-Negative Bacterial Infections | Phase 2 | Status: COMPLETED